Aligos Therapeuticsinc Stock Price on April 27, 2021
| ALGS Stock | USD 0.79 0.05 5.95% |
If you're considering investing in Aligos Stock, it is important to understand the factors that can impact its price. As of today, the current price of Aligos TherapeuticsInc stands at 0.79, as last reported on the 18th of April 2024, with the highest price reaching 0.83 and the lowest price hitting 0.76 during the day. Aligos TherapeuticsInc appears to be dangerous, given 3 months investment horizon. Aligos TherapeuticsInc secures Sharpe Ratio (or Efficiency) of 0.0687, which signifies that the company had a 0.0687% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Aligos TherapeuticsInc, which you can use to evaluate the volatility of the firm. Please makes use of Aligos TherapeuticsInc's Downside Deviation of 5.28, mean deviation of 3.62, and Risk Adjusted Performance of 0.0367 to double-check if our risk estimates are consistent with your expectations.
At this time, Aligos TherapeuticsInc's Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 193.5 M in 2024, whereas Common Stock is likely to drop 4,767 in 2024. . At this time, Aligos TherapeuticsInc's Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 0.49 in 2024, whereas Price Earnings Ratio is likely to drop (0.51) in 2024. Aligos Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Aligos |
Sharpe Ratio = 0.0687
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ALGS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.7 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.39 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Aligos TherapeuticsInc is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aligos TherapeuticsInc by adding it to a well-diversified portfolio.
Price Book 0.8218 | Enterprise Value Ebitda 0.5749 | Price Sales 4.8727 | Shares Float 36.7 M | Wall Street Target Price 4 |
Aligos TherapeuticsInc Valuation on April 27, 2021
It is possible to determine the worth of Aligos TherapeuticsInc on a given historical date. On April 27, 2021 Aligos was worth 2.0 at the beginning of the trading date compared to the closed value of 2.07. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aligos TherapeuticsInc stock. Still, in general, we apply an absolute valuation method to find Aligos TherapeuticsInc's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aligos TherapeuticsInc where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aligos TherapeuticsInc's related companies.
| Open | High | Low | Close | Volume | |
04/04/2022 | 2.00 | 2.16 | 2.00 | 2.07 | 829,900 |
| 2.08 | 2.24 | 2.08 | 2.14 | 444,200 |
| Backtest Aligos TherapeuticsInc | | | Aligos TherapeuticsInc History | | | Aligos TherapeuticsInc Valuation | Next |
Aligos TherapeuticsInc Trading Date Momentum on April 27, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Aligos TherapeuticsInc Fundamentals Correlations and Trends
By evaluating Aligos TherapeuticsInc's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aligos TherapeuticsInc's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aligos financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Aligos TherapeuticsInc Stock history
Aligos TherapeuticsInc investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aligos is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aligos TherapeuticsInc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aligos TherapeuticsInc stock prices may prove useful in developing a viable investing in Aligos TherapeuticsInc
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 64.3 M | 36.6 M | |
| Net Loss | -86.4 M | -90.8 M |
Aligos TherapeuticsInc Quarterly Net Working Capital |
|
Aligos TherapeuticsInc Stock Technical Analysis
Aligos TherapeuticsInc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Aligos TherapeuticsInc Period Price Range
Low | April 4, 2022
| High |
2.00 | 2.07 |
Aligos TherapeuticsInc April 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Aligos TherapeuticsInc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aligos TherapeuticsInc shares will generate the highest return on investment. By undertsting and applying Aligos TherapeuticsInc stock market strength indicators, traders can identify Aligos TherapeuticsInc entry and exit signals to maximize returns
Aligos TherapeuticsInc Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aligos TherapeuticsInc's price direction in advance. Along with the technical and fundamental analysis of Aligos Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aligos to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0367 | |||
| Jensen Alpha | 0.1319 | |||
| Total Risk Alpha | (0.17) | |||
| Sortino Ratio | 0.0364 | |||
| Treynor Ratio | 0.1022 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aligos TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more information on how to buy Aligos Stock please use our How to Invest in Aligos TherapeuticsInc guide.Note that the Aligos TherapeuticsInc information on this page should be used as a complementary analysis to other Aligos TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Aligos Stock analysis
When running Aligos TherapeuticsInc's price analysis, check to measure Aligos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aligos TherapeuticsInc is operating at the current time. Most of Aligos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Aligos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aligos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Aligos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Aligos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aligos TherapeuticsInc. If investors know Aligos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aligos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.242 | Quarterly Revenue Growth (0.24) | Return On Assets (0.37) | Return On Equity (0.89) |
The market value of Aligos TherapeuticsInc is measured differently than its book value, which is the value of Aligos that is recorded on the company's balance sheet. Investors also form their own opinion of Aligos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Aligos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aligos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Aligos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aligos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aligos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aligos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.